ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression.

BMC Cancer · 2008 · PMC2442841 · PMID 18582378

Europe PMC DOI

hedged sentences

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

of borderline significancep = 0.050actually significant

Additionally performed Kruskal-Wallis tests further confirmed the non-significant associations of ADAM9 expression with M-status (p = 0.096), nodal status (p = 0.098), whereas residual tumour status was of borderline significance (p = 0.050).

also in 2,624 other papers

highly significantno p-value reported

The Cox multivariate survival analysis revealed no independent prognostic value for ADAM9 expression and tumour grading whereas pT-and pM-stage remained highly significant (Table 5 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.